|
Volumn 22, Issue 6, 2011, Pages 877-878
|
Hormonal contraception and HIV Risk: Evaluating marginal-structural-model assumptions
|
Author keywords
[No Author keywords available]
|
Indexed keywords
COMBINED ORAL CONTRACEPTIVE AGENT;
MEDROXYPROGESTERONE ACETATE;
ORAL CONTRACEPTIVE AGENT;
UNCLASSIFIED DRUG;
COVARIANCE;
HAZARD RATIO;
HORMONAL CONTRACEPTION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INFECTION RISK;
LETTER;
MARGINAL STRUCTURAL MODEL;
PREGNANCY;
PRIORITY JOURNAL;
PROPORTIONAL HAZARDS MODEL;
SENSITIVITY ANALYSIS;
STATISTICAL ANALYSIS;
CONTRACEPTIVE AGENTS, FEMALE;
CONTRACEPTIVES, ORAL, HORMONAL;
DATA INTERPRETATION, STATISTICAL;
DELAYED-ACTION PREPARATIONS;
HIV INFECTIONS;
HUMANS;
MEDROXYPROGESTERONE ACETATE;
MODELS, STATISTICAL;
RISK FACTORS;
|
EID: 80053609535
PISSN: 10443983
EISSN: 15315487
Source Type: Journal
DOI: 10.1097/EDE.0b013e3182319910 Document Type: Letter |
Times cited : (4)
|
References (7)
|